CAS: 26295-56-7 - N-Trifluoroacetyladriamycin

Formel: C₂₉H₂₈F₃NO₁₂

InChl: InChI=1S/C29H28F3NO12/c1-10-22(36)13(33-27(41)29(30,31)32)6-17(44-10)45-15-8-28(42,16(35)9-34)7-12-19(15)26(40)21-20(24(12)38)23(37)11-4-3-5-14(43-2)18(11)25(21)39/h3-5,10,13,15,17,22,34,36,38,40,42H,6-9H2,1-2H3,(H,33,41)/t10-,13-,15-,17-,22+,28-/m0/s1

InChI Key: InChIKey=RQIOYWADAKTIJC-XUKKXQNXSA-N

SMILES: O=C1C=2C=CC=C(OC)C2C(=O)C=3C(O)=C4C(=C(O)C13)CC(O)(C(=O)CO)CC4OC5OC(C)C(O)C(NC(=O)C(F)(F)F)C5

Synonyme:

• 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)-
• 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl]oxy]-, (8S-cis)-
• (8S,10S)-7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione
• 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)-
• L-lyxo-Hexopyranoside, 3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-, (1S,3S)- α-

N-Trifluoroacetyl Doxorubicin

CAS: 26295-56-7

• Formel: C₂₉H₂₈F₃NO₁₂
• Molekulargewicht: 639.53

N-Trifluoroacetyladriamycin

CAS: 26295-56-7

N-Trifluoroacetyladriamycin, Valrubicin's metabolite, treats bladder cancer; it's an analog of doxorubicin, infused into the bladder.

• Formel: C₂₉H₂₈F₃NO₁₂
• Farbe und Form: Solid
• Molekulargewicht: 639.533

N-Trifluoroacetyldoxorubicin

CAS: 26295-56-7

N-Trifluoroacetyldoxorubicin is an analog of daunorubicin. It has been shown to damage the cell membrane, …

• Formel: C₂₉H₂₈F₃NO₁₂
• Reinheit: Min. 95%
• Molekulargewicht: 639.53 g/mol